MedTrace Logo

An Open-label, Randomized, 2-Period, Crossover, Pharmacokinetics Study

NCT05360576 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-07-19

No results posted yet for this study

Summary

An Open-label, Randomized, 2-Period, Crossover Study to Assess the Comparative Pharmacokinetics of LSP-5415 and NuvaRing® in Healthy Adult Females

Conditions

  • Pregnancy Prevention

Interventions

DRUG

LSP-5415 (etonogestrel/ethinyl estradiol vaginal ring)

To prevent pregnancy

DRUG

NuvaRing Vaginal Ring

To prevent pregnancy

Sponsors & Collaborators

  • Lupin Research Inc

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-24
Primary Completion
2022-07-04
Completion
2022-07-04
FDA Drug
Yes

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05360576 on ClinicalTrials.gov